Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular ...
30m
Hosted on MSNFDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancerThe US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
Those rehired by the Trump administration include at least 10 FDA staffers responsible for reviewing the safety of new food ...
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
Positive data from prospective, multi-center trials confirmed compelling effectiveness and five-year safety with high satisfaction from both ...
Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...
Robert F. Kennedy Jr. said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances.
The death toll rose to 12 people in the Listeria outbreak tied to frozen supplemental shakes sold to long-term care facilities, according to CDC. Pope Francis remains in critical condition but showed ...
The U.S. Food & Drug Administration (FDA) announced the recall of Frozen Supplemental Shakes due to potential Listeria contamination. According to the FDA, Lyons Magnus LLC ...
Hours after the US Office of Personnel Management had directed agencies that responses to its email were optional, Musk again ...
Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results